Discussion
September is National ITP Awareness Month in the U.S., a time when advocates work to raise awareness and support research into immune thrombocytopenia (ITP).
While standard preventive treatments may reduce the risk of disease flares and organ damage in people with congenital thrombotic thrombocytopenic purpura (TTP), flare-ups can still occur among patients on prophylaxis, a new study notes. Further, certain preventive therapies long used for treating the rare condition carry notable safety risks,…
Latest news & perspectives
Discussion
Discussion
Pregnancy is full of numbers, especially when you’re living with immune thrombocytopenia (ITP). And for someone who doesn’t enjoy math, that’s not ideal. There…
Discussion
HMB-002, an experimental antibody-based treatment from Hemab Therapeutics for von Willebrand disease (VWD), increased levels of von Willebrand factor (VWF) and improved measures…
